Concepedia

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

Elisabeth I. Heath, Barbara Burtness, Lawrence Kleinberg, Ronald R. Salem, Stephen C. Yang, Richard F. Heitmiller, Marcia Irene Canto, Jonathan Knisely, Mark Topazian, Elizabeth A. Montgomery,

Investigational New Drugs · 2006 · 46 citations · 14 references

DOI

Concepts

References

14

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)

Gillian Murphy, Mark I. Cockett, Robin V. Ward et al. · Biochemical Journal · 1991 · 453 citations · Full text

, , +17

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · The Journal of Pathology · 1998 · 285 citations

, , +12

Phase II Evaluation of Preoperative Chemoradiation and Postoperative Adjuvant Chemotherapy for Squamous Cell and Adenocarcinoma of the Esophagus

Elisabeth I. Heath, Barbara Burtness, Richard F. Heitmiller et al. · Journal of Clinical Oncology · 2000 · 132 citations

, , +16

REGULATION OF MATRIX METALLOPROTEINASES - THEIR ROLE IN TUMOR INVASION AND METASTASIS

DW Cottam, RC Rees · International Journal of Oncology · 1993 · 116 citations

, , +17